Papers

Contribution of tuberculosis to slim disease in Africa

Department of Histopathology, University College London Medical School, London WC1E 6JJ Division of HIV/AIDS, NCID, Centers for Disease Control and Prevention, Atlanta, Georgia Projet RETRO-CI, Abidjan,Ivory Coast, University Hospital, Abidjan, Ivory Coast Institute of Tropical Medicine, Antwerp, Belgium Correspondence to: Dr Lucas.

Abstract

Objectives : To assess the contribution of tuberculosis to the aetiology of the HIV wasting syndrome (slim) in Africa, a condition usually considered an enteropathy.
Methods : Clinical examination and representative necropsy study of adult patients positive for HIV.
Setting : Hospital medical wards in Abidjan, Ivory Coast.
Subjects : Adults positive for HIV.
Main outcome measures : CD4 T lymphocyte counts before death, clinical and anthropometric data, and gross and microscopic pathology. Results - Necropsy was done on 212 HIV positive adults. Tuberculosis was found in 41 of 93 with the clinical HIV wasting syndrome and in 32 of 119 without (odds ratio 2.1, 95% confidence interval 1.2 to 4.0). A significant association existed between the prevalence of tuberculosis at necropsy and the degree of cadaveric wasting (no wasting 25% (15/59); moderate wasting 40% (23/58); skeletal wasting 44% (42/95); P=0.02). Wasting was also associated with a history of chronic diarrhoea, but no association existed between diarrhoea and tuberculosis. Median CD4 T lymphocyte counts were lowest in wasted patients irrespective of findings at necropsy and in those with chronic diarrhoea (<60x10⁶/l).
Conclusion : Wasting and chronic diarrhoea are late stage manifestations of HIV disease in Africa. The importance of tuberculosis as a contributing factor in the pathogenesis of the slim syndrome has been underestimated. In nearly half of patients dying with severe wasting, tuberculosis was the dominant pathological finding.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Tuberculosis and slim disease in Africa

P Godrey-Faussett, A Mwinga, M Hosp, R Baggaley, J Porter, and R Msiska
BMJ 1994 309: 1230-1231. [Extract] [Full Text]

This article has been cited by other articles:

• Marston, B., De Cock, K. M. (2004). Multivitamins, Nutrition, and Antiretroviral Therapy for HIV Disease in Africa. NEJM 351: 78-80 [Full text]  
• Paton, N. I, Ng, Y.-M., Chee, C. B., Persaud, C., Jackson, A. A (2003). Effects of tuberculosis and HIV infection on whole-body protein metabolism during feeding, measured by the [15N]glycine method. Am. J. Clin. Nutr. 78: 319-325 [Abstract] [Full text]  
• Zumla, A., Malon, P., Henderson, J., Grange, J. M (2000). Impact of HIV infection on tuberculosis. Postgrad. Med. J. 76: 259-268 [Abstract] [Full text]  
• Daily, J. P., Sadeghi, S. (2000). Case 5-2000- A 35-Year-Old Man with a Painful Abdominal Mass and Fever. NEJM 342: 493-500 [Full text]  
• Batman, P A, Kapembwa, M S, Miller, A R O, Sedgwick, P M, Lucas, S, Sewankambo, N K, Serwadda, D, Pudney, J, Moody, A, Harris, J R W, Griffin, G E (1998). HIV enteropathy: comparative morphometry of the jejunal mucosa of HIV infected patients resident in the United Kingdom and Uganda. Gut 43: 350-355 [Abstract] [Full text]  
• Lucas, S., De Cock, K. M (1996). Authors' reply. BMJ 312: 1302d-1303 [Full text]  
• Kelly, P., Lungu, F., Keane, E., Baggaley, R., Kazembe, F., Pobee, J., Farthing, M. (1996). Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double blind controlled trial. BMJ 312: 1187-1191 [Abstract] [Full text]  
• Godrey-Faussett, P, Mwinga, A, Hosp, M, Baggaley, R, Porter, J, Msiska, R (1994). Tuberculosis and slim disease in Africa. BMJ 309: 1230b-1231 [Full text]